Loading live market data…

Madrigal Pharmaceuticals, Inc.

NASDAQ:MDGL

$550.25 USD

$13.39 (2.49%)

Volume
259.46K
Average Volume
328.03K
Market Capitalization
$12.69B
P/E Ratio
-42.99
Dividend Yield
0.00%
Price Target
$649.00
Year High
$615.00
Year Low
$286.44
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.50

MDGL Estimated and Actual Revenue by Quarter

MDGL Estimated and Actual EPS by Quarter

MDGL Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 4 207.13M 232.33M 224.34M 206.95M 232.12M 224.13M
2027-09-30 5 185.01M 207.51M 200.37M 184.84M 207.32M 200.19M
2027-06-30 4 169.11M 189.68M 183.15M 168.95M 189.5M 182.99M
2027-03-31 4 150.37M 168.66M 162.86M 150.23M 168.5M 162.71M
2026-12-31 8 138.67M 155.54M 150.19M 138.55M 155.4M 150.05M
2026-09-30 9 131.72M 137.91M 134M 131.6M 137.79M 133.88M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 4 115.86M 134.65M 128.69M 752.62M 844.17M 815.14M
2027-09-30 5 73.86M 85.84M 82.04M 672.22M 753.99M 728.06M
2027-06-30 4 50.28M 58.43M 55.84M 614.45M 689.19M 665.49M
2027-03-31 4 14.42M 16.75M 16.01M 546.36M 612.82M 591.74M
2026-12-31 8 -1.23M -1.06M -1.17M 503.87M 565.16M 545.72M
2026-09-30 9 -40.69M -24.22M -31.71M 478.59M 501.11M 486.89M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 4 600.72M 673.79M 650.62M 2 3.9906 4.63776 4.43252
2027-09-30 5 536.55M 601.81M 581.11M 1 2.5442 2.95679 2.82594
2027-06-30 4 490.44M 550.09M 531.17M 1 1.73173 2.01257 1.9235
2027-03-31 4 436.09M 489.13M 472.31M 2 0.49655 0.57708 0.55154
2026-12-31 8 402.17M 451.09M 435.58M 2 -0.04233345 -0.03642618 -0.04046
2026-09-30 9 381.99M 399.97M 388.62M 4 -1.40163 -0.8341 -1.09207